Business · 09/07/2012Updated: 10/17/2026 · 1 min read
Wyeth Pharmaceuticals Withdraws Approval of DURACT Capsules
Summary
Wyeth Pharmaceuticals, Inc., now a subsidiary of Pfizer, Inc., has voluntarily withdrawn its approval of a new drug application for DURACT (bromfenac sodium) Capsules from the FDA, waiving its right to a hearing.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →